This Article Free upon publication Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Taubman, M. Search for Related Content PubMed Articles by Taubman, M.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:1.)
© 2009 American Heart Association, Inc.

Editorials

Arteriosclerosis, Thrombosis, and Vascular Biology, 2009

Mark Taubman

From the Editors of Arteriosclerosis, Thrombosis, and Vascular Biology.

Correspondence to Mark Taubman, Editor-in-Chief, c/o ATVB Editorial Office, 10 Circle Drive, Suite 12, North Liberty, IA 52317. E-mail atvb@atvb.org

An extract of the first 250 words of the full text is provided, because this article has no abstract.

As we begin 2009, The Editorial Board and Staff of the ATVB Journal would like to wish our readers a Happy New Year and take this opportunity to review the state of the journal in 2008 and describe our plans for the coming year.

2008 was indeed an extraordinary year, highlighted by a global economic crisis and an unprecedented political campaign in the United States. It is likely that these events will have important positive and negative impacts on cardiovascular medicine and research in the years to come. 2008 also saw changes in the ATVB journal, albeit less monumental. These include a redesign of the cover and table of contents. The cover, in its boldness, allows us easy recognition. The table of contents allows us to group articles within a discipline, while still maintaining their identity as Atherosclerosis, Thrombosis, or Vascular Biology. Soon this change will also be implemented within our eTOC—please visit atvb.ahajournals.org to sign up if you have not already.

The impact factor of the Journal increased this year to more than 7 (Figure 1), continuing a trend that was a hallmark of the previous Editorship of Donald Heistad and his colleagues. We are working hard to continue this trend. Our acceptance rate has remained steady at approximately 17%. Submissions may have plateaued, a trend that has been seen by many journals and is likely multifactorial, including a reduction in grant funding in the United States. Manuscripts continue to be submitted from a diverse set of . . . [Full Text of this Article]